ANORO ELLIPTA (UMECLIDINIUM/VILANTEROL)

Anoro Ellipta is a prescription medication used for the long-term, once-daily maintenance treatment of chronic obstructive pulmonary disease (COPD). It is a combination medication that contains two active ingredients: Umeclidinium Bromide and Vilanterol Trifenatate.

Umeclidinium Bromide is an anticholinergic bronchodilator that works by blocking the action of acetylcholine, a neurotransmitter responsible for narrowing the airways in the lungs. By inhibiting the effects of acetylcholine, umeclidinium helps to relax and open up the airways, making it easier to breathe.

Vilanterol Trifenatate, on the other hand, is a long-acting beta2-adrenergic agonist (LABA). It stimulates beta2-adrenergic receptors in the airway smooth muscles, causing them to relax and dilate. This action helps to improve airflow and relieve symptoms of COPD such as wheezing, shortness of breath, and coughing.

The combination of Umeclidinium and Vilanterol in Anoro Ellipta provides dual bronchodilation, meaning it targets two different pathways to widen the airways and improve lung function. By combining an anticholinergic and a LABA, Anoro Ellipta offers a synergistic effect, providing enhanced bronchodilation and better control of COPD symptoms.

Anoro Ellipta comes in the form of a dry powder inhaler. Each inhalation delivers a fixed dose of umeclidinium and vilanterol. It is important to follow the prescribed dosage and instructions provided by your healthcare provider for the safe and effective use of this medication. CanadaPharmacy Pro offers the best Anoro Ellipta cost, so check our website to get exciting offers.

Anoro Ellipta falls under the following therapeutic classifications:

• Anticholinergics: Umeclidinium bromide, one of the active ingredients in Anoro Ellipta, is an anticholinergic agent. It works by blocking the action of acetylcholine, a neurotransmitter involved in the contraction of smooth muscles in the airways. By inhibiting acetylcholine, umeclidinium helps to relax the airway muscles, leading to bronchodilation.
• Respiratory Tract Agents: Anoro Ellipta is primarily used to manage and improve respiratory function in individuals with COPD. It acts as a bronchodilator, helping to relax and widen the airways, which leads to improved airflow and reduced symptoms of COPD.
• Long-Acting Beta2-Adrenergic Agonists (LABAs): The other active ingredient in Anoro Ellipta, vilanterol trifenatate, belongs to the class of long-acting beta2-adrenergic agonists. It stimulates beta2-adrenergic receptors in the smooth muscles of the airways, causing them to relax and dilate. This results in improved airflow and relief of COPD symptoms.

Anoro Ellipta is available in different strengths, typically indicated by the dosage of its active ingredients, Umeclidinium Bromide and Vilanterol Trifenatate. However, please note that the specific strengths of medications can vary by country and may be subject to change.

Commonly available strength of Anoro Ellipta is 55/22 mcg. This strength indicates that each inhalation delivers a dose containing 55 micrograms of umeclidinium bromide and 22 micrograms of Vilanterol Trifenatate.

Anoro Ellipta is primarily indicated for the treatment of chronic obstructive pulmonary disease (COPD) in adults. It is not approved for use in the management of other medical conditions. COPD is a progressive respiratory condition characterized by airflow limitation and difficulty breathing.

Anoro Ellipta is specifically prescribed for the long-term, once-daily maintenance treatment of COPD, including chronic bronchitis and/or emphysema. It is used to improve symptoms, such as shortness of breath, wheezing, and coughing, and to enhance lung function.

It is important to note that Anoro Ellipta is not intended for the relief of acute symptoms or for the treatment of asthma. It is specifically designed for the management of COPD and should only be used under the supervision and guidance of a healthcare professional. You can get a reasonable Anoro Ellipta cost at CanadaPharmacy Pro.

The usual recommended dose for adults is one inhalation of Anoro Ellipta (55/22 mcg) once daily. Each inhalation delivers a fixed dose containing 55 micrograms of umeclidinium bromide and 22 micrograms of vilanterol Trifenatate.

It is important to use Anoro Ellipta regularly as prescribed, even if you are not experiencing symptoms. Do not exceed the prescribed dose unless specifically instructed by your healthcare provider.

Anoro Ellipta is administered via inhalation, specifically through the oral inhalation route. It is delivered using a dry powder inhaler called the Ellipta inhaler. The Ellipta inhaler is a breath-activated device that allows the medication to be inhaled directly into the lungs. You can buy Anoro Ellipta online from CanadaPharmacyPro.

Some of the common side effects associated with the use of Anoro Ellipta inhaler include:

• Nausea
• Upper respiratory tract infection.
• Influenza (flu)
• Headache
• Back pain
• Common cold symptoms (nasopharyngitis).
• Sinusitis (inflammation of the sinuses).
• Cough
• Diarrhea
• Joint pain
• Muscle spasms

Some of the known drug interactions with the Anoro Ellipta inhaler include:

• Other Anticholinergic Medications: Concurrent use of multiple anticholinergic medications may increase the risk of side effects such as dry mouth, constipation, blurred vision, and urinary retention.
• Beta-Blockers: Use caution when combining Anoro Ellipta with beta-blockers, as they can antagonize the effects of the beta2-agonist component of Anoro Ellipta, potentially reducing its effectiveness in managing COPD symptoms.
• Monoamine Oxidase Inhibitors (MAOIs): Anoro Ellipta should not be used in combination with MAOIs or within 2 weeks of discontinuing MAOI therapy, as it may increase the risk of hypertensive crisis.
• Other Long-Acting Beta2-Agonists (LABAs): Combining Anoro Ellipta with other LABAs may lead to an increased risk of cardiovascular effects, such as increased heart rate or blood pressure. Anoro Ellipta price is available at the best price at CanadaPharmacyPro, so check our website.

The contraindications for Anoro Ellipta include:

• Hypersensitivity: Anoro Ellipta is contraindicated in individuals who have a known hypersensitivity or allergy to umeclidinium, vilanterol, or any of the inactive ingredients present in the medication.
• Severe Hypersensitivity to Milk Proteins: Anoro Ellipta contains lactose monohydrate, which is derived from milk proteins. It is contraindicated in individuals with severe hypersensitivity to milk proteins or who have been diagnosed with galactose intolerance, lactase deficiency, or glucose-galactose malabsorption.

Do not use this medication and inform your healthcare provider about any medical conditions you have:

• Diabetes
• Heart conditions
• High blood pressure
• Seizures
• Urinary retention
• Thyroid problems
• Narrow-angle glaucoma

So, if you are in need, buy Anoro Ellipta online at the best price from CanadaPharmacyPro.

• Store the drug at room temperature, between 20°C and 25°C
• Keep it in a dry place away from direct sunlight and heat sources.

If you are considering to buy Anoro Ellipta online or any other drug online, it is vital to be careful and only buy from reputable pharmacies like CanadaPharmacy Pro. It is also suggested to talk to a licensed doctor before purchasing any drug.

If you are looking to purchase Anoro Ellipta or any prescription drugs from an Online Pharmacy worldwide, you may order from a safe and accredited international pharmacy like CanadaPharmacyPro that offers the best possible Anoro Ellipta price. CanadaPharmacyPro offers the best Anoro Ellipta cost and a good quality medication as well.